Comosystems Research
CMO Research Results
Background
Comosystems has over 10 years of high level research and development that resulted in Compensating Magnetic Oscillator technology. With his background in Pharmaceutical development, founder, Maurice Fillion-Robin knew that the new technology would not be credible or taken seriously unless it was tested under controlled laboratory conditions initially, and later in the field under real life conditions. He also knew that in-house research would be viewed with suspicion and would not be considered credible either. Various different scientists in different fields and in different universities and research establishments around the World performed rigorous testing procedures that were written up before being peer-reviewed and published. No other product in this market has been tested and proven over so many different biological markers and parameters as CMO.
Research is ongoing to ensure that CMO technology is as effective today with the rapidly expanding EMF networks and frequencies as it was when it was first marketed. Comosystems can therefore say with confidence that CMO technology is able to mitigate for the range of existing EMFs commonly found in the home, the office and out and about in towns and cities etc.
Intracellular Calcium
The results displayed in the graph above were obtained by Dr. Govindan DAYANITHI at Université de Montpellier
Both Dr Andrew Goldsworthy of Imperial College London and Prof Martin Pall of Washington State University have independently confirmed that EMFs interfere with Voltage Gated Calcium Channels, enabling an influx of Calcium ions into the cell which initiates an inflammatory cascade.
Symptoms of EMS sensitivity can be eradicated by using Calcium Channel blocker pharmaceutical drugs, which confirms the adverse effect on calcium ions by EMFs.
The optimization and normalization of the calcium fluxes into the cell is obtained by means of the CMO targeting voltage-gated ion channels in cooperation with intrinsic stochastic resonance.
This normalization results in the improvement or disappearance of the symptoms listed below:
Consequences of Calcium ion deregulation
- Tiredness
- Confusion and difficulty thinking clearly or concentrating
- Mental and physical inertia, lethargy.
- loss of appetite, or anorexia, nausea
- Constipation
- muscular weakness andheart rhythm disorders
- abnormal skin sensation of the lips, tongue, fingers, hands and feet,
- contractures and muscle spasms, cramps
Exhaled Nitric Oxide (NO)
The results displayed in the graph above were obtained by Prof. V.N Binhi*, Dr E.V Stepanov, General Physics Institute RAS, Moscow, Russia
First stage:
- 16 days EMF exposure,
- 45 min/day
Second stage :
- 11 days EMF exposure with CMO Easycall technology
- 45 min/day
- NO levels normalised over this time
Nitric oxide (NO) is a free radical that attacks all cellular structures. Increased NO levels indicate higher cellular stress
Normalization of NO levels using CMO results in the improvement or disappearance of the symptoms listed below:
*Author of Magnetobiology text book (available on Amazon)
Implications of normalised NO with CMO
- Reduced carcinogenic risk
- Slowing down of early aging
- Reduction of neuro-degenerative diseases risks.
- Reduction of vertigo and imbalances
- Reduction of tinnitus.
Heat Shock Protein (Hsp70)
The results displayed in the graph above were obtained by Prof. Reba Goodman, Columbia University, New York, USA
- Alzheimer's disease
- Parkinson's disease
- Huntington's disease
- Creutzfeldt-Jakob disease
- Cystic fibrosis
- Gaucher's disease
- Many other degenerative and neurodegenerative disorders
Normalisation of Hsp70 by CMO results in the benefits listed below:
- Optimization of the proper functioning of proteins.
- Reduced risk of neurodegenerative and cancerous pathologies
- Protection against toxicity of heavy metals.
Binding Activity of the Serum Response Element
The results displayed in the graph above were obtained by Prof. Reba Goodman, Columbia University, New York, USA
- Damaged muscle structure, function and development
- Higher risk of cardiac failure
- Fragility of the digestive tract (liver, stomach, intestines)
- Tumour development.
Normalisation of SRE by CMO results in the benefits listed below:
- Normal development of muscle structure and function
- Better muscle fascia repair
- Prevention of myocardiac failure = heart attack
- Prevention of digestive disorders and cancers.
- Optimization of cellular growth regulation
Impact on Macrophage DNA
The results displayed in the graph above were obtained by Dr Youbicier-Simo B-J. (Tecnolab), Dr Fernandez A. (CNRS, Univ. Montpellier)
- Increased carcinogenic risk with potential tumour development.
CMO reduces the damage to gDNA by about 39% thereby providing some but not total protection:
- CMO reduces the increased carcinogenic risk.
- Reducing exposure to EMFs is still important even if you are using EMF protection.
Melatonin Production
The results displayed in the graph above were obtained by Prof M. Bastide, Dr B-J Youbicier-Simo, Laboratoire d'Immunologie et de Parasitologie,Faculté de Pharmacie, Université de Montpellier
Health implications of reduced melatonin
- Increase of free radicals leading to oxidative stress
- Sleep disorders, tiredness, fatiguability.
- Premature aging
- Acceleration of tumour process
- Epileptic seizures
- Reduced muscle mass and muscle maintenance.
CMO protection benefits
- Reduced inflammation
- Reduced premature aging
- Reduced risk of cancer
- Reduced neuro-degenerative diseases, diabetes and epilepsy
- Improvement of sleep and mood with better general healing
- Better maintenance of muscle mass and recovery.
Cortisol Production
The results displayed in the graph above were obtained by Prof L. Bonhomme-Faivre,Laboratoire de Pharmacologie, Hôpital Paul Brousse, Paris
- helping to control the blood sugar level
- helping the body deal with stress
- helping to control blood pressure and blood circulation.
Health implications of low cortisol
- Extreme fatigue.
- Weight loss and decreased appetite.
- Darkening of your skin (hyperpigmentation)
- Low blood pressure, even fainting.
- Salt craving.
- Low blood sugar (hypoglycemia)
- Nausea, diarrhea or vomiting (gastrointestinal symptoms)
- Abdominal pain.
Benefits of CMO from helping normalise cortisol
- Helps control blood sugar levels,
- Regulates metabolism,
- Supports immune function
- Reduces inflammation
- Assist with memory formulation.
- Has a controlling effect on salt and water balance
- Helps control blood pressure.
IgG Antibody Production
The results displayed in the graph above were obtained by Prof M. Bastide, Dr B-J Youbicier-Simo, Laboratoire d'Immunologie et de Parasitologie,Faculté de Pharmacie, Université de Montpellier
Health implications of reduced IgG production
- Decreased immune defences
- Weak resistance to infections (viruses, bacteria, yeasts, parasites).
CMO protection benefits
- Better immune function
- Greater resistance to bacterial, viral, yeast and parasite infections
Monocyte Production
The results displayed in the graph above were obtained by Prof L. Bonhomme-Faivre, Laboratoire de Pharmacologie, Hopital Paul Brousse, Paris
Health implications of reduced Monocyte production
- Decreased immune defences
- Weak resistance to infections (viruses, bacteria, yeasts, parasites).
- Faster progression of liver fibrosis
- Slower muscle regeneration
- Faster progression of Alzheimer's Disease
CMO protection benefits
- Better immune function
- Greater resistance to bacterial, viral, yeast and parasite infections
- Reduced cancer and spreading of cancer
- Faster muscle regeneration
- Better liver repair
- Slower progression of Alzheimer's Disease
Neuron Proliferation and Repair
The results displayed in the graph above were obtained by Dr B-J Youbicier-Simo, Tecnolab, France looking at neurons within the brain Hippocampus.
Health implications of Hippocampus degeneration
- Stress and depression
- Alzheimer's disease
- Other dementias
CMO protection benefits
- Reduced stress
- Helps prevent depression
- Improved learning abilities
- Reduced risks of Alzheimer‘s disease and other dementias
Embryonic mortality
The results displayed in the graph above were obtained by Prof M. Bastide, Dr B-J Youbicier-Simo, Pr Y. Grigoriev
Health implications
- Increased infertility
- Increased embryonic malformations and death
- Increased miscarriage
CMO protection benefits
- Preservation of fertility
- Reduced embryonic malformations and death
- Reduced risk of miscarriage
It should be noted that the results graph above include a result that most people would not have expected. The yellow bar in the last group of results showed that shielding from all EMFs with a Faraday cage-like arrangement actually increased embryonic mortality. This is because it cut out those natural EMFs that life on earth evolved to live within and that have beneficial effects on our biology. This is a good example of why it is important to have biological proof of efficacy when using EMF protection. Something that sounds like it might reasonably have a beneficial effect may in fact do the opposite, however well-intentioned.
Infertility amongst the younger generations has been rising rapidly and most notably in countries that typically use high levels of technology that rely on and emit EMFs. Singapore had a 31% drop in reproduction between 2016 and 2017 at the same time that Macao had a 26% drop. South Korea dropped 11% at the same time and a further 9% drop in the 1st half of 2018.
European studies give rise for even greater concern. Two studies published in 2018 showed that in Finland and Denmark 78.5% and 79% of males respectively are either in the low fertility or infertile ranges. This was supported in 2019 when a study from Switzerland showed that 62% of young males are infertile.
When the average cost of private infertility treatment in the UK is as much as £5,000+ per cycle with only 29% average success rate for women under 35*, the message couldn't be any clearer - avoid all EMFs as much as possible, don't carry mobile phones in trouser pockets when switched on especially and our advice is to use CMO technology to cover all other exposures. (*Source: NHS website)
Corneal Injuries
The results displayed in the graph above were obtained by Prof. M. Miyata, Tokyo Univ. Japan
CMO protection benefits
- Improved vision
- Better accommodation to far and near objects
- Reduced eye irritation and soreness
- Reduced eye strain.
Stress in the Work Place
The results displayed in the graph above were obtained by Jukes Associate Ergonomic & Environmental Consultants/Tecnolab, overseen by Reading University.
Quantified mood test
The results displayed above were obtained by Prof. T. Canavan Luton Univ. UK
Stroop Colour World Test
The results displayed above were obtained by Dr. Marande –Médecine du travail Hôpital Cochin - Paris
The top graph measured the base rate of stress in people who were regularly exposed to EMFs. The second graph below was obtained after using CMO technology for the interceding month. Given that not all stress can be attributed to EMFs, it is suggestive that the beneficial effects of CMO as demonstrated by the individual marker graphs above may also mitigate for other unidentified sources of stress that can disrupt cortisol, voltage-gated ion channels such as Calcium, Hsp70 etc.